I've had a better look through the prospectus, if my understanding is correct, most of the $63m ish raised from the IPO will be used to fund Photoassay machines already contracted out, so this won't be used to pursue growth beyond that which is forecast.
Their FY23 Forecast is a steep increase in revenue but NPAT of negative ($5m) primarily because of employee expenses.
Wish you the best but I think this is going to get hammered in the first few weeks of listing and I will try to short if I get borrow. Let's see how it goes after a few months!
C79 Price at posting:
0.0¢ Sentiment: Sell Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)